• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More or Call (407) 374-6986

Wednesday 11/14/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

anti-infectives

  • 7:26 PM

    Two Contract Manufacturing Organizations Engaged to Produce Clinical Trial Material PR Newswire CRANFORD, N.J., Sept. 8, 2016 CRANFORD, N.J., Sept. 8, 2016, CTXR, /PRNewswire/ — Citius Pharmaceuticals, Inc. (“Citius”) (OTC QB: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that it has initiated manufacturing for the company’s clinical trial of Mino-Lok ™, an antibiotic lock solution used to salvage central venous catheters (CVCs) and to treat catheter related bloodstream infections (CRBSIs).

    Read more
  • 3:13 PM

    CRANFORD, N.J., Sept. 7, 2016, CTXR, /PRNewswire/ — Citius Pharmaceuticals, Inc. (“Citius”) (OTC QB: CTXR), a specialty pharmaceutical company dedicated to developing and commercializing adjunctive cancer care and critical care drug products, announced today that its Chairman, Len Mazur, will present at the Rodman & Renshaw 18th Annual Global Investment Conference. The Conference will be held on September 11-13, 2016 at the Lotte New York Palace Hotel, New York City. Event: Rodman & Renshaw 18th Annual Global Investment Conference Location:

    Read more
  • 4:04 PM

    MELBOURNE, Fla., Oct 06, 2014 (BUSINESS WIRE) — Lighting Science Group (OTCQB:LSCG) is pleased to announce the awarding of US patent #8,841,864 titled “Tunable LED lamp for producing biologically-adjusted light.” This patent gives Lighting Science exclusivity to create a lamp/luminaire that is adjustable within 3 spectrally significant light configuration settings: pre-sleep, general illumination, and phase shift. The settings can help users sleep better, manage their circadian rhythm, and even effect time zone phase shifts. “This is the 40th patent granted

    Read more
Public Wire Banner